期刊文献+

肿瘤分子靶向治疗进展 被引量:4

Advances of Molecular Targeted Therapy
原文传递
导出
摘要 分子靶向治疗作为肿瘤治疗的新手段,以其低毒、高效等特性正成为肿瘤研究的热点。分子靶向药物包括表皮生长因子受体通路抑制剂、抗血管生成剂、环氧化酶-2抑制剂、抗CD20单克隆抗体等。大量临床应用结果表明,分子靶向药物在肿瘤治疗中具有显著疗效。本文综述了近年来肿瘤分子靶向治疗领域的进展。 Molecular targeted therapy is a new approach for tumor treatment,with the advantages of lower toxicity and higher efficiency.This approach has become a critical focus of tumor research.It includes epidermal growth factor receptor inhibitors,anti-angiogenesis drugs,cyclooxygenase-2 inhibitors,anti-CD20 monoclonal antibodies,etc.A large number of clinical applications show that molecular targeted therapy has significant effects on tumor.This review summarized the progress of molecular targeted therapy in recent years.
作者 张迪 戈伟
出处 《武汉大学学报(医学版)》 CAS 北大核心 2011年第5期705-708,共4页 Medical Journal of Wuhan University
关键词 肿瘤 分子靶向治疗 表皮生长因子受体 抗血管生成 Tumor Molecular Targeted Therapy Epidermal Growth Factor Receptor Anti-Angiogenesis
  • 相关文献

参考文献11

二级参考文献128

共引文献700

同被引文献32

  • 1高志强,韩宝惠.分子基因检测预测EGFR-TKI靶向治疗非小细胞肺癌的疗效——第43届美国临床肿瘤学会年会非小细胞肺癌靶向治疗动态[J].中国医药生物技术,2007,2(6):472-473. 被引量:3
  • 2陆舜,虞永峰,李子明.肺癌分子靶向治疗进展[J].中华肿瘤杂志,2005,27(11):701-704. 被引量:5
  • 3张力,王志强.大肠癌靶向治疗进展[J].中国癌症杂志,2007,17(1):18-23. 被引量:19
  • 4李勇,张湘茹,孙燕.非小细胞肺癌的靶向治疗进展[J].癌症进展,2007,5(2):151-157. 被引量:19
  • 5孙燕,石远凯.临床肿瘤内科手册[M].第5版,北京:人民卫生出版社,2006:491-492.
  • 6Miller K’Wang ML, Gralow J,et al.Paclitaxel puls bevacizumab ver-sus paclitaxel alone for metastatic breast cancer[J].N Engl J Med,2007,357:2666-2676.
  • 7Damen C W, Schellens J H, Beijnen J H. Bioanalytical meth- od for the quantification of therapeutic monoclonal antibod- ies and their application in clinical pharmacokinetic studies [J]. Hum Antibodies, 2009,18(3):47-73.
  • 8Beum P V, Kennedy A D, Taylor R P. Three new as- says for rituximab based on its immunological activity or anti- genic properties: analyses of sera and plasmas of RTX-treat- ed patients with chronic lymphocytic leukemia and other B cell lymphomas[J]. J Immunol Methods, 2004,289(1-2):97-109.
  • 9Liu X F, Wang X, Weaver R J, et al. Validation of a gyro- lab assay for quantification of rituximab in human serum[J]. J Pharmacol Toxicol Methods, 2012,65(3):107-114.
  • 10Boross P, Leusen J H. Mechanisms of action of CD20 antibod- ies[J]. Am J Cancer Res, 2012,2(6):676-690.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部